-+ 0.00%
-+ 0.00%
-+ 0.00%

Samsung Biologics Largest Shareholder Group's Stake Falls to 73.61% From 74.30%

PUBT·11/18/2026 07:25:25
Listen to the news
Samsung Biologics Largest Shareholder Group's Stake Falls to 73.61% From 74.30%
  • Samsung Biologics' largest shareholder group increased holdings by 1,352,170 shares to 35,746,107, according to its November 18, 2026, disclosure.
  • The group's stake fell to 73.61% from 74.3% in the November 2 report.
  • Samsung C&T acquired 782,818 newly issued common shares on November 17, bringing its stake to 42.66%.
  • Samsung Electronics acquired 567,503 newly issued common shares the same day, taking its holding to 30.92%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Samsung Biologics Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261118800334), on November 18, 2026, and is solely responsible for the information contained therein.